Oral cryotherapy for management of chemotherapy-induced oral mucositis in haematopoietic cell transplantation: a systematic review

被引:13
作者
Alsulami, Faizah Jabr [1 ]
Shaheed, Sadr ul [2 ,3 ]
机构
[1] Univ Sydney, Susan Wakil Sch Nursing & Midwifery, Sydney, NSW, Australia
[2] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England
[3] Univ Oxford, Biomed Res Ctr, Oxford, England
关键词
Haematological malignancies; Chemotherapy; Oral cryotherapy; Oral mucositis; Haematopoietic cell transplantation; HIGH-DOSE MELPHALAN; INDUCED STOMATITIS; REDUCES MUCOSITIS; PREVENTION; THERAPY; METHOTREXATE; SEVERITY; REGIMENS; MYELOMA; LASER;
D O I
10.1186/s12885-022-09539-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Oral mucositis (OM) is known to be the most common and challenging side effect of conditioning chemotherapy in haematopoietic cell transplant (HCT). This side effect causes significant morbidity and may delay the treatment plan, as well as increase therapeutic expenses. There are few clinical trials in the literature that indicate any kind of treatment or prevention methods are effective. Therefore, the aim of this study is to perform a systematic review of literature and examine the effectiveness of oral cryotherapy (OC) in management of chemotherapy-induced OM in patients with haematological malignancies undergoing a HCT. Methods A systematic literature search was conducted, using the electronic databases PubMed, Embase, MEDLINE and Scopus. A total of 322 papers were identified and 9 papers were analysed based on defined inclusion and exclusion criteria. The quality of the chosen primary studies was appraised using the COCHRANE risk of bias assessment tool. Results Nine randomized controlled trials, analysing 658 participants; control group (n = 289, age mean +/- SD; 41.15 +/- 21) and treatment group (n = 369, age mean +/- SD; 39.15 +/- 20), were included in this systematic review. Seven studies had significantly addressed the effectiveness of OC (p value < 0.05), in reducing the incidence of developing severe OM in the adult population undergoing HCT, especially when the conditioning regimen protocols included high dose of alkylating agent such as melphalan. Conclusion This review supports the use of OC for prevention of OM in patients undergoing HCT, with high-dose of melphalan conditioning protocols. It is recommended that more studies be conducted to compare efficacy and duration of OC with other chemotherapeutic agents with relatively short plasma half-lives. The heterogeneity of the trials demonstrated the need to regulate the validated assessment tools and similar interventions that would enable comparisons and analyses of treatment effects based on well-designed RCTs.
引用
收藏
页数:13
相关论文
共 50 条
[1]   Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients [J].
Aisa, Y ;
Mori, T ;
Kudo, M ;
Yashima, T ;
Kondo, S ;
Yokoyama, A ;
Ikeda, Y ;
Okamoto, S .
SUPPORTIVE CARE IN CANCER, 2005, 13 (04) :266-269
[2]  
Alvarino-Martin Carlos, 2014, J Clin Exp Dent, V6, pe74, DOI 10.4317/jced.51313
[3]  
[Anonymous], 1979, HDB REP RES CANC TRE
[4]   The Effects of Oral Cryotherapy on Chemotherapy-Induced Oral Mucositis in Patients Undergoing Autologous Transplantation of Blood Stem Cells: A Clinical Trial [J].
Askarifar, Marzieh ;
Lakdizaji, Sima ;
Ramzi, Mani ;
Rahmani, Azad ;
Jabbarzadeh, Faranak .
IRANIAN RED CRESCENT MEDICAL JOURNAL, 2016, 18 (04)
[5]   A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations [J].
Atilla, Erden ;
Atilla, Pinar Ataca ;
Demirer, Taner .
BALKAN MEDICAL JOURNAL, 2017, 34 (01) :1-9
[6]  
BeTheMatch/NationalMarrowDonorProgram(NMDP), 2015, INT MARR DON REG REA
[7]  
Bhatia S, 2011, EXPERT REV HEMATOL, V4, P437, DOI [10.1586/EHM.11.39, 10.1586/ehm.11.39]
[8]   The lived experience of patients in protective isolation during their hospital stay for allogeneic haematopoietic stem cell transplantation [J].
Biagioli, Valentina ;
Piredda, Michela ;
Mauroni, Maria Rita ;
Alvaro, Rosaria ;
De Marinis, Maria Grazia .
EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2016, 24 :79-86
[9]   A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis [J].
Bjordal, Jan Magnus ;
Bensadoun, Rene-Jean ;
Tuner, Jan ;
Frigo, Lucio ;
Gjerde, Kjersti ;
Lopes-Martins, Rodrigo A. B. .
SUPPORTIVE CARE IN CANCER, 2011, 19 (08) :1069-1077
[10]   Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis [J].
Blijlevens, N. ;
Sonis, S. .
ANNALS OF ONCOLOGY, 2007, 18 (05) :817-826